Genmab, Rina-S, Rinatabart Sesutecan, GEN1184, Ovarian Cancer, Platinum-Resistant Ovarian Cancer, RAINFOL-01, Antibody Drug Conjugate, ADC, FRα, Folate Receptor Alpha, Exatecan

Copenhagen, Denmark, October 3, 2026 Genmab has announced results from the Phase 1/2 RAINFOL™-01 trial evaluating rinatabart sesutecan (Rina-S®)...